Tenpoint Therapeutics
Develops treatments to rejuvenate vision in the aging eye
$235MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops treatments to rejuvenate vision in the aging eye
Pitching Hillhouse? Send the deck from a free RoundOS data room and see which pages they read.